Inventor profile of:

Rafet Basar

City:

Houston, Texas

Country:

United States

Published Applications:

26

Last publication date:

2025-09-11

Top Assignees for applications by Rafet Basar

The entities that hold a legal rights for patent applications filed by inventor Basar Rafet:

Recent patent applications by Basar Rafet

Rafet Basar from Houston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11
US20250281612A1
Human necessities

CD27-EXTRACELLULAR DOMAIN CAR TO TARGET CD70-POSITIVE TUMORS

#2 | 2025-08-14
US20250255905A1
Human necessities

BCMA CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#3 | 2025-08-07
US20250249098A1
Human necessities

CRYOPRESERVATION OF NK CELL PRODUCTS FOR OFF-THE-SHELF IMMUNOTHERAPY

#4 | 2025-07-17
US20250228942A1
Human necessities

METHODS FOR ACTIVATION AND EXPANSION OF ENGINEERED NATURAL KILLER CELLS AND COMBINATIONS WITH ANTIBODIES

#5 | 2025-03-06
US20250074950A1
Chemistry; metallurgy

METHODS FOR PRODUCTION OF THERAPEUTIC IMMUNE CELLS HAVING ENHANCED METABOLIC FITNESS AND COMPOSITIONS THEREOF

#6 | 2024-12-12
US20240408203A1
Human necessities

ENGINEERING NK CELLS WITH A CAR CONSTRUCT WITH OPTIMAL SIGNALING

#7 | 2024-11-21
US20240382593A1
Human necessities

ANTIBODY LOADED IMMUNE CELLS AND METHODS FOR USE IN CANCER TREATMENT

#8 | 2024-10-24
US20240350543A1
Human necessities

BCMA chimeric antigen receptors and uses thereof

#9 | 2024-10-03
US20240325444A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR TO TARGET TROP-2-POSITIVE CANCERS

#10 | 2024-10-03
US20240325443A1
Human necessities

CD3-EXPRESSING NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY

#11 | 2024-08-15
US20240269285A1
Human necessities

POLYPEPTIDES TARGETING CD70-POSITIVE CANCERS

#12 | 2024-08-01
US20240252539A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR TO TARGET HLA-G-POSITIVE CANCERS

#13 | 2024-06-13
US20240189357A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS TO TARGET CD5-POSITIVE CANCERS

#14 | 2024-05-23
US20240165162A1
Human necessities

METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND COMBINATIONS WITH BISPECIFIC ANTIBODIES

#15 | 2023-11-30
US20230383257A1
Chemistry; metallurgy

PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM

#16 | 2023-07-06
US20230210902A1
Human necessities

SARS-COV-2-SPECIFIC T CELLS

#17 | 2023-02-09
US20230045174A1
Chemistry; metallurgy

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS

#18 | 2022-12-22
US20220403418A1
Chemistry; metallurgy

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF B CELLS

#19 | 2022-12-22
US20220401479A1
Human necessities

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS

#20 | 2022-12-08
US20220389383A1
Chemistry; metallurgy

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF NK CELLS

#21 | 2022-12-01
US20220378739A1
Human necessities

NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS

#22 | 2022-09-15
US20220288121A1
Human necessities

CELL CRYOPRESERVATION MEDIUM

#23 | 2022-06-09
US20220175837A1
Human necessities

METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF

#24 | 2022-02-03
US20220031749A1
Human necessities

MULTIPLEX GENOME EDITING OF IMMUNE CELLS TO ENHANCE FUNCTIONALITY AND RESISTANCE TO SUPPRESSIVE ENVIRONMENT

#25 | 2021-07-29
US20210230548A1
Chemistry; metallurgy

NATURAL KILLER CELLS ENGINEERED TO EXPRESS CHIMERIC ANTIGEN RECEPTORS WITH IMMUNE CHECKPOINT BLOCKADE

#26 | 2021-05-20
US20210147800A1
Chemistry; metallurgy

METHODS FOR PRODUCING REGULATORY IMMUNE CELLS AND USES THEREOF

InventorID:

5083516 ⎘